Generation Bio Co reports results for the quarter ended in December - Earnings Summary

Generation Bio

06/03/2024 23:28

* Generation Bio Co  GBIO.OQ  reported a quarterly adjusted
loss
of 53 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -55 cents.  The mean expectation of
seven analysts for the quarter was for a loss of 45 cents per
share. Wall Street expected results to range from -52 cents
to -32 cents per share.
    * Revenue was $2.88 million​; analysts expected $860.00
thousand. 
    * Generation Bio Co's reported EPS for the quarter was a
loss
of 53 cents​.
    * The company reported a quarterly loss of $35.19 million.
    * Generation Bio Co shares had risen by 73.3% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Generation Bio Co
is $7.00 
This summary was machine generated from LSEG data March 6 at
11:28 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.45          -0.53          Missed
 Sep. 30 2023      -0.50          -0.43          Beat
 Jun. 30 2023      -0.50          -0.47          Beat
 Mar. 31 2023      -0.46          -0.53          Missed